Assessment and planning for medical evacuation by air to the EU of patients with Ebola virus disease and people exposed to Ebola virus
The aim of this document is to guide decision-making when there is a perceived need for medical evacuation by air of an infected or exposed person from an Ebola-affected country to an EU Member State.
Assessing and planning medical evacuation flights to Europe for patients with Ebola virus disease and people exposed to Ebola virus
The aim of this document is to guide decision-making when there is a perceived need for medical evacuation by air of an Ebola-infected or Ebola-exposed person from an Ebola-affected country to an EU Member State.
Rapid risk assessment: Human infection with avian influenza A(H5N1) virus, Egypt - 1st update, 13 March 2015
Human cases and fatalities due to influenza A(H5N1) virus continue to increase in Egypt, with cases from the country now accounting for the highest number of human cases reported worldwide.
Legionnaires’ disease in Europe, 2013
This surveillance report is based on the 2013 disease surveillance data collected by the European Legionnaires’ Disease Surveillance Network.
Rapid Risk Assessment: Outbreak of invasive meningococcal disease in the EU associated with a mass gathering event in Japan, 21 August 2015
This rapid risk assessment considers the risk to the EU of an outbreak of invasive meningococcal disease in the UK and Sweden associated with the 23rd World Scout Jamboree in Japan.
Significant increase in travel associated Dengue Fever in GermanyArchived
Few and limited occasions of dengue virus transmission have recently been reported in Europe, which were not unexpected considering the presence of the vector Aedes albopictus
Imported methicillin-resistant Staphylococcus aureus, SwedenArchived
The authors analyzed data on 444 imported cases of methicillin-resistant Staphylococcus aureus (MRSA) in Sweden during the period 2000-2003. The risk for MRSA carriage or infection in returning travellers ranged from 0.1 per million travellers returning from Nordic countries to 59.4 per million travellers returning from North Africa and the Middle East.
Panton-Valentine leukocidin-positive Staphylococcus aureus infections in returning travelersArchived
The authors present data on 15 individuals infected by Panton-Valentine leukocidin (PVL) -producing strains of Staphylococcus aureus. Intra-familial spread was documented in one case, and occupational transmission was most likely in another case. spa typing of the strains revealed a broad range of variants, though some strains were clonally related. Methicillin-resistant Staphylococcus aureus (MRSA) was found in three cases.
Illness in French Travelers to Senegal: Prospective Cohort Follow-up and Sentinel Surveillance DataArchived
Evaluating health complaints in returning travellers through a sentinel surveillance system does not always reflect the spectrum of health problems that occur during travel. In this paper, the comparison of cohort surveys and sentinel surveillance data is used to better describe the epidemiology of health complaints during and after travel.
Scientific advances – Intravenous artesunate for severe Malaria in Travelers, EuropeArchived
This study describes the outcome of 25 travellers with severe malaria who returned from malaria-endemic regions and were treated at 7 centres in Europe with intravenous artesunate. Among these 25 patients, one child and 24 adults (mean ± SD age 44.1 ± 16.1 years), 10 patients received the dosing regimen for artesunate initially recommended by WHO and 11 received artesunate, 2.4 mg/kg/dose.